Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
...Ki of 27 pM BOSTON, June 25, 2007 /PRNewswire/ -- arisaph Pharmaceuticals, Inc., a privately held drug disco...ferentiated efficacy profile in diabetic patients. arisaph is currently completing IND enabling studies and e...cts to initiate first-in-man testing in 2008. arisaph designed ARI-2243 as a once a day, orally active, ...Industry News Feeds : Press Room : Thomson Reuters
2006 SEP 8 - -- Arisaph Pharmaceuticals, Inc. ... To trigger the second closing, Arisaph successfully achieved its key development ...Summary of KOS PHARMACEUTICALS INC - Yahoo! Finance
which later changed its name to Arisaph Pharmaceuticals, Inc. (" Arisaph"), through the purchase of shares of a new series of convertible ...Arisaph Pharmaceuticals, Inc. Announces at the ADA</b> that Its Potent ...
BOSTON, June 8 /PRNewswire/ -- Arisaph Pharmaceuticals, Inc. ... Arisaph filed an IND for ARI-2243 during the first quarter of 2008 and has ...Hung-Sen Lai Arisaph Pharmaceuticals Email @arisaph.com
Lead411's profile of Arisaph Pharmaceuticals's Dir Medicinal Chemistry, Hung-Sen ... Lead411 subscription email addresses ( @arisaph.com ) of the executives ...Article: Arisaph Picked.(News)(Brief Article) - Chain Drug Review
Register today for a free trial, credit card req'd. Find Chain Drug Review articles plus many other academic journal articles, magazine articles & newspaper archives.Arisaph Pharmaceuticals, Inc. :: Arisaph Pharmaceuticals Announces at ...
Arisaph Pharmaceuticals, Inc., a privately held drug discovery biopharmaceutical company, announced today at the 68th session of the American Diabetes Association ...